On the mechanism of the pharmacological activity of the new nonsteroidal antiinflammatory agent 4'-acetamidophenyl-2-(5'-p-toluyl-1'-methylpyrrole)acetate.
4-Acetamidophenyl-2-(5'-p-toluyl-1'-methylpyrrole)acetate (AU 8001), a tolmetin derivative, prepared by esterification with paracetamol, showed antiinflammatory-antirheumatic activity in animal models. This activity is believed to be largely due to the ability of the drug to inhibit the synthesis of prostaglandins. Furthermore, there is evidence that AU 8001 may also reduce the leucocyte immigration into inflamed tissues. Moreover, AU 8001 had no effects, after oral administration, on histamine- and 5-hydroxytryptamine-induced increase of vascular permeability or lysosome membrane stabilization.